cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Nrx Pharmaceuticals Inc
12 own
15 watching
Current Price
$1.25
$0.07
(5.93%)
logo-nrxp
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
84.55M
52-Week High
52-Week High
3.54
52-Week Low
52-Week Low
0.4899
Average Volume
Average Volume
0.21M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization84.55M
icon52-Week High3.54
icon52-Week Low0.4899
iconAverage Volume0.21M
iconDividend Yield--
iconP/E Ratio--
What does the Nrx Pharmaceuticals Inc do?
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.
Read More
How much money does Nrx Pharmaceuticals Inc make?
News & Events about Nrx Pharmaceuticals Inc.
PR Newswire
1month ago
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Close of Definitive Settlement Agreements Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Close of Definitive Settlement Agreements PR Newswire GENEVA and RADNOR, Pa., Dec. 20, 2022 Ad hoc announcement...
Accesswire
1month ago
GENEVA, SWITZERLAND and RADNOR, PA / ACCESSWIRE / December 20, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ('Relief'), and NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ('NRx Pharmaceuticals'), a clinical-stage central nervous system biopharmaceutical...
PR Newswire
2 months ago
NRx Receives Nasdaq Notice of Listing Compliance NRx Receives Nasdaq Notice of Listing Compliance PR Newswire RADNOR, Pa., Dec. 2, 2022 RADNOR, Pa., Dec. 2, 2022 /PRNewswire/ --NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ('NRx Pharmaceuticals', the 'Company'), a clinical-stage...
Accesswire
2 months ago
GENEVA, SWITZERLAND and RADNOR, PA / ACCESSWIRE / November 14, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTD) (' Relief '), and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) (' NRx Pharmaceuticals '), today announced that they have entered into definitive...
PR Newswire
2 months ago
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements PR Newswire GENEVA and RADNOR, Pa., Nov. 14, 2022 Ad hoc...
Frequently Asked Questions
Frequently Asked Questions
What is Nrx Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Nrx Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Nrx Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Nrx Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Nrx Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Nrx Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Nrx Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Nrx Pharmaceuticals Inc?
plus_minus_icon
What percentage is Nrx Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Nrx Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.25
$0.07
(5.93%)
logo-nrxp
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00